About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials | 4,005 Studies Recruiting

Clinical TrialsAlzheimer's Disease

Alzheimer's Disease Clinical Trials

Browse 4,005 clinical trials for alzheimer's disease. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 4,005 trials

RecruitingCerebro Spinal Fluid Collection (CSF)Cognitive neurodegenerative diseases are a major public health issue. At present, the diagnosis of certainty is still based on anatomopathological analyses.NCT04844060·Strasbourg CompletedDominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.The purpose of this study is to assess the safety, tolerability, biomarker and cognitive efficacy of investigational products in subjects who are known to have an Alzheimer's…NCT04623242·Birmingham, Alabama and 24 others

Related Searches

alzheimerstrials dementiatrials

Data from ClinicalTrials.govTerms

CompletedPredicting the Conversion From Mild Cognitive Impairment to DementiaMild cognitive impairment (MCI) is believed to be the early stage of dementia. The investigators assume that some psychological and imaging risks may predict the conversion.NCT01823666·Beijing, Beijing Municipality

CompletedProgression Delaying Effect of Escitalopram in Alzheimer's DiseaseThis study aimed to test whether escitalopram would slow the brain atrophy in patients with mild to moderate AD over the 52-week period.NCT00702780·Chuncheon and 3 others

RecruitingA Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's DiseaseNCT06976203·Fullerton, California and 127 others

CompletedSleep, Aging and Risk for Alzheimer's DiseaseOur preliminary data show for in cognitively-normal elderly, that Sleep Disordered Breathing (SDB) is associated with the increase of cerebrospinal fluid (CSF) phosphorylated-Tau…NCT01962779·New York, New York and 1 other

CompletedPost-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-The purpose of this study is to investigate the following about donepezil hydrochloride administration in patients with mild or moderate Alzheimer's Disease in clinical practice…NCT01129596·Aisai, Aichi-ken and 721 others

CompletedAgeing Gut Brain InteractionsThis research project will address a desperate need for evidence on how diet could be used to treat and improve symptoms of Alzheimer's disease (AD).NCT03593941·Aberdeen, Grampian

CompletedDeep Brain Stimulation for the Treatment of Alzheimer's DiseaseThe purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS)as a treatment option for patients with cognitive, behavioral, and…NCT01559220·Columbus, Ohio

CompletedStudy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeThe purpose of this study is to assess xaliproden's potential capacity of slowing the deterioration of cognitive and global functions in patients with mild to moderate Alzheimer's…NCT00104013·Mesa, Arizona and 40 others

CompletedSafety Study of CTS21166 to Treat Alzheimer DiseaseThis study is the first human exposure for the drug candidate CTS21166 in healthy male volunteersNCT00621010·Salt Lake City, Utah

RecruitingBlood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.The goal of this study is to determine how blood biomarker tests (ptau217 and ptau217/Aβ42) performed in primary care influence the patient trajectory in individuals with…NCT07666113·Leuven

CompletedHearing Instruments in Alzheimer's DiseaseThere is a strong connection between hearing loss and cognitive impairment, particularly dementia, in old age.NCT02294513·Toronto, Ontario

Not yet recruitingDeep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia PatientsThis clinical trial aims to evaluate the clinical efficacy and safety of Deep Cervical Lymphaticovenous Anastomosis (DLVA) in patients aged 50-80 with moderate to severe…NCT06978946·Shanghai, Shanghai Municipality

CompletedIdentification of Graphic Markers of Neurocognitive Disorders (MG)The diagnosis of neurocognitive disorders such as early Alzheimer's disease (AD) or primary progressive aphasia (PPA) is particularly difficult and constantly evolving, often…NCT05537688·Montreal, Quebec

RecruitingBrain Wave Informed Non-invasive Brain Stimulation: Improving Neural Networks of Working Memory in Dementia: a Proof-of-concept StudyWorking memory helps us hold information for a short time so one can think and make decisions. It keeps thoughts on track.NCT07673770·Hamilton, Ontario

CompletedA Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive ImpairmentThe purpose of this follow-up study is to assess the long-term safety and tolerability of galantamine in individuals with mild cognitive impairment who participated in a previous…NCT00240695

RecruitingA Feasiblity Study of Green Activity Program for People Living With Memory ChallengesThe purpose of this study is to test the Green Activity Program that was designed with people living with memory challenges and their study partners to see if it can be done and…NCT06403345·Bloomington, Indiana

CompletedA Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's DiseaseThis is a study to evaluate biodistribution, pharmacokinetics and safety of \[18F\]THK-5351 positron emission computed tomography in Cognitively Healthy Subjects and Patients with…NCT03112096·Seoul

RecruitingChina Longitudinal Aging and Cognitive Impairment StudyThis is a multi-center longitudinal study that consists of five cohorts: cognitive normal aging (CN), Subjective cognitive impairment (SCI), mild cognitive impairment (MCI)…NCT05468905·Hangzhou, Zhejiang and 1 other

PreviousPage 3 of 201Next